NDC 0054-0137 Galantamine Hydrobromide
Solution Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0054 - Hikma Pharmaceuticals Usa Inc.
- 0054-0137 - Galantamine Hydrobromide
Product Characteristics
8 MM
54;731
54;421
Product Packages
NDC Code 0054-0137-49
Package Description: 100 mL in 1 BOTTLE
Product Details
What is NDC 0054-0137?
What are the uses for Galantamine Hydrobromide?
What are Galantamine Hydrobromide Active Ingredients?
Which are Galantamine Hydrobromide UNII Codes?
The UNII codes for the active ingredients in this product are:
- GALANTAMINE HYDROBROMIDE (UNII: MJ4PTD2VVW)
- GALANTAMINE (UNII: 0D3Q044KCA) (Active Moiety)
Which are Galantamine Hydrobromide Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSPOVIDONE (15 MPA.S AT 5%) (UNII: 68401960MK)
- ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)
- POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)
- POLYDEXTROSE (UNII: VH2XOU12IE)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIACETIN (UNII: XHX3C3X673)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- SACCHARIN SODIUM (UNII: SB8ZUX40TY)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for Galantamine Hydrobromide?
- RxCUI: 860901 - galantamine HBr 4 MG in 1 mL Oral Solution
- RxCUI: 860901 - galantamine hydrobromide 4 MG/ML Oral Solution
- RxCUI: 860901 - galantamine HBr 4 MG per 1 ML Oral Solution
Which are the Pharmacologic Classes for Galantamine Hydrobromide?
* Please review the disclaimer below.
Patient Education
Galantamine
Galantamine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Galantamine is in a class of medications called acetylcholinesterase inhibitors. It works by increasing the amount of a certain natural substance in the brain that is needed for memory and thought. Galantamine may improve the ability to think and remember or slow the loss of these abilities in people who have AD. However, galantamine will not cure AD or prevent the loss of mental abilities at some time in the future.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".